Cyrus Badshah

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M. Marty, Per Ljungman, Roy F. Chemaly et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

Susanne K. Kjær, Mari Nygård, Karin Sundström et al. · EClinicalMedicine · 2020 · 195 citations · Full text

Medicine, Oncology, Preventive Medicine +17

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Per Ljungman, Michael Schmitt, Francisco M. Marty et al. · Clinical Infectious Diseases · 2019 · 159 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

Per Ljungman, Roy F. Chemaly, Fareed Khawaya et al. · Clinical Infectious Diseases · 2024 · 149 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Domenico Russo, Michael Henry Schmitt, Sylvain Pilorge et al. · The Lancet Haematology · 2023 · 100 citations

Medicine, Immunology, Infectious Diseases +15